Beverly Winikoff

1 та иш

*Gynuity Health Projects, New York, USA

1. Acceptability and feasibility of the use of 400 μg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: Evidence from Uzbekistan

   Sheila Raghavan, Tamar Tsereteli, A. Kamilov +5

   МақолаReproductive Health and ContraceptionThe European Journal of Contraception & Reproductive Health Care20130 иқтибос

   ABIABI:AkademIndex/openalex/2013.article.000062